PBH240517C75000
- 0.30
- 0.000.00%
Prestige Consumer Healthcare Newsroom
Dramamine Ditches the 'Drama on Deck' With a Summer Sweepstakes Giving Away Two Private Yacht Charters
The #1 brand in motion related nausea relief teamed up with TV personality and former chief steward Kate Chastain to share how she keeps summer travel drama-freeTARRYTOWN, N.Y., May 22, 2024 /PRNewsw
Prestige Consumer Hlthcr Is Maintained at Buy by Canaccord Genuity
Prestige Consumer Hlthcr Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Prestige Consumer, Maintains $80 Price Target
Prestige Consumer Healthcare: A Strong Buy Amid Solid Financials and Strategic Growth Initiatives
Prestige Consumer Hlthcr Price Target Maintained With a $65.00/Share by DA Davidson
Prestige Consumer Hlthcr Price Target Maintained With a $65.00/Share by DA Davidson
Express News | DA Davidson Maintains Neutral on Prestige Consumer, Maintains $65 Price Target
Prestige Consumer Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 -0.09% DA Davidson $65 → $65 Maintains Neutral 06/26/2023 -7.78% DA Davidson → $60 Reiterates N
Prestige Consumer (PBH) Q4 Earnings Miss, Operating Margin Falls
Prestige Consumer Healthcare Inc. PBH delivered fourth-quarter fiscal 2024 earnings per share (EPS) of $1.02, a 4.7% decline from the year-ago period’s figure. The metric also missed the Zacks Consensus Estimate by 10.5%.
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)
Prestige Consumer Healthcare Inc (PBH) (Q4 2024) Earnings Call Transcript Highlights: ...
Prestige Consumer Healthcare Needs Even More Suppliers -- Market Talk
1443 ET - Prestige Consumer Healthcare's supply-chain strategy, which helped during pandemic-era disruptions, didn't stop issues in 4Q. CEO Ron Lombardi says on a call with analysts that the company's
Earnings Call Summary | Prestige Consumer Healthcare(PBH.US) Q4 2024 Earnings Conference
The following is a summary of the Prestige Consumer Healthcare Inc (PBH) Q4 2024 Earnings Call Transcript:Financial Performance:Prestige's Q4 performance fell short due to supply chain pressures and u
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday
Health care stocks rose pre-bell Wednesday, with the Health Care Select Sector SPDR Fund (XLV) recently 0.3% higher and the iShares Biotechnology ETF (IBB) up 0.6%. Arcutis Biotherapeutics (ARQT) rall
Analysts Are Bullish on Top Healthcare Stocks: Nyxoah (NYXH), Prestige Consumer Healthcare (PBH)
Express News | Prestige Consumer Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results and Issued Weak Guidance
Prestige Consumer Healthcare | 10-K: Annual report
Update: Prestige Consumer Healthcare Shares Fall Pre-Bell After Fiscal Q4 Miss
(Updates with the recent stock movement in the headline and first paragraph.) Prestige Consumer Healthcare's (PBH) shares fell more than 7% in Wednesday's premarket activity after the company reported
Cisco, Prestige Consumer Healthcare And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:Wall Street expects Cisco Systems, Inc. (NASDAQ:CSCO) to report qu
Stocks to Watch: Nextracker, Prestige Consumer Healthcare, VirTra
By Ben Glickman Nextracker's revenue rose 42%, to $737 million, in the fourth quarter, topping Wall Street's forecasts. The company said it saw strong demand for its solar tracker and software soluti
Prestige Consumer Healthcare Fiscal Q4 Adjusted Earnings, Revenue Drop; Fiscal 2025 Outlook Set; Shares Fall After Hours
Prestige Consumer Healthcare (PBH) reported fiscal Q4 adjusted earnings late Tuesday of $1.02, down from $1.07 a year earlier. Analysts surveyed by Capital IQ expected $1.14. Revenue in the quarter en